Literature DB >> 7076111

Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release.

H Ring-Larsen, B Hesse, J H Henriksen, N J Christensen.   

Abstract

Systemic and renal neurovascular reactivity was investigated in eight patients with cirrhosis and in eight control subjects with fatty liver during postural changes. In the supine position, mean renal blood flow averaged 1.51 and 2.97 ml per gm per min in patients and controls, respectively (p less than 0.02). During tilting, renal blood flow changed significantly (p less than 0.05) and equally in patients and controls (15 degrees head-down tilt: 12 and 13% increase, respectively; 60 degrees head-up tilt: 27 and 32% decrease, respectively). Mean arterial blood pressure was significantly lower in patients than controls (82 vs. 95 mm Hg, p less than 0.05) but did not change during the tilt. Plasma norepinephrine (NE) concentration was significantly higher in another eight patients with cirrhosis than in eight healthy controls (mean: 0.45 vs. 0.21 ng per ml in recumbency, p less than 0.02). Following 60 degrees head-up tilt, the increase in NE was similar in both groups. In another 10 patients with cirrhosis in recumbency, the splanchnic arterial-hepatic venous extraction of NE averaged 0.43 (p less than 0.01), and the hepatic clearance of NE averaged 315 ml per min which is of the same order as previously reported in healthy controls. The right kidney released NE into the systemic circulation. Renal venous plasma NE exceeded arterial concentration by 34% (p less than 0.01). It is concluded that sympathetic nervous activity is enhanced in patients with cirrhosis, and that this hyperactivity may be responsible for renal vasoconstriction in these patients. However, systemic and renal neurovascular reactivity seems to be maintained even at an advanced stage of the disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076111     DOI: 10.1002/hep.1840020303

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  29 in total

1.  Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE.

Authors:  D Sacerdoti; M Balazy; P Angeli; A Gatta; J C McGiff
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis.

Authors:  K Lenz; H Hörtnagl; W Druml; G Grimm; A Laggner; B Schneeweisz; G Kleinberger
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

3.  Hepatorenal syndrome.

Authors:  Bimaljit Singh Sandhu; Arun J Sanyal
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

4.  Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?

Authors:  R Jalan; E H Forrest; D N Redhead; J F Dillon; P C Hayes
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

5.  Endurance training reduces renal vasoconstriction to orthostatic stress.

Authors:  Erin E Conboy; Amy E Fogelman; Charity L Sauder; Chester A Ray
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-18

Review 6.  Pathophysiology of sympathoadrenal system.

Authors:  R Giorgino
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

7.  Serum catecholamines and dysautonomia in diabetic gastroparesis and liver cirrhosis.

Authors:  Naeem Aslam; Archana Kedar; Harsha S Nagarajarao; Kartika Reddy; Hani Rashed; Teresa Cutts; Caroline Riely; Thomas L Abell
Journal:  Am J Med Sci       Date:  2015-08       Impact factor: 2.378

8.  Reductions in portal pressure by selective beta 2-adrenoceptor blockade in patients with cirrhosis and portal hypertension.

Authors:  D Bihari; D Westaby; A Gimson; I Crossley; J Harry; R Williams
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

9.  Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.

Authors:  M Huonker; Y O Schumacher; A Ochs; S Sorichter; J Keul; M Rössle
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

10.  Renal function impairment induced by change in posture in patients with cirrhosis and ascites.

Authors:  M Bernardi; C Santini; F Trevisani; M Baraldini; A Ligabue; G Gasbarrini
Journal:  Gut       Date:  1985-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.